Genpact Limited (NYSE:G)‘s stock had its “buy” rating reiterated by Robert W. Baird in a research note issued on Friday. They presently have a $38.00 target price on the business services provider’s stock. Robert W. Baird’s target price indicates a potential upside of 21.87% from the stock’s previous close.

Several other equities research analysts have also recently commented on the company. Zacks Investment Research upgraded Genpact Limited from a “sell” rating to a “hold” rating in a research note on Friday. Cantor Fitzgerald reiterated a “buy” rating and set a $36.00 price objective on shares of Genpact Limited in a research note on Wednesday. Cowen and Company restated a “buy” rating and issued a $33.00 price target on shares of Genpact Limited in a research note on Thursday, October 12th. SunTrust Banks, Inc. restated a “buy” rating and issued a $34.00 price target on shares of Genpact Limited in a research note on Monday, October 9th. Finally, BMO Capital Markets reaffirmed a “hold” rating on shares of Genpact Limited in a report on Friday, October 6th. Three research analysts have rated the stock with a hold rating and seven have assigned a buy rating to the company. Genpact Limited has an average rating of “Buy” and an average target price of $33.13.

Genpact Limited (NYSE:G) traded up $0.04 during trading on Friday, hitting $31.18. The company had a trading volume of 659,300 shares, compared to its average volume of 887,567. The company has a debt-to-equity ratio of 0.82, a current ratio of 1.73 and a quick ratio of 1.73. Genpact Limited has a fifty-two week low of $23.16 and a fifty-two week high of $31.93. The company has a market capitalization of $6,018.80, a PE ratio of 20.25, a price-to-earnings-growth ratio of 2.14 and a beta of 0.58.

Genpact Limited (NYSE:G) last announced its quarterly earnings data on Tuesday, November 7th. The business services provider reported $0.46 EPS for the quarter, topping the Zacks’ consensus estimate of $0.36 by $0.10. The firm had revenue of $708.82 million during the quarter, compared to analyst estimates of $685.25 million. Genpact Limited had a return on equity of 24.21% and a net margin of 10.18%. The company’s revenue was up 9.3% on a year-over-year basis. During the same period last year, the company earned $0.37 earnings per share. equities analysts predict that Genpact Limited will post 1.46 EPS for the current fiscal year.

TRADEMARK VIOLATION WARNING: This story was reported by The Cerbat Gem and is owned by of The Cerbat Gem. If you are viewing this story on another website, it was illegally stolen and republished in violation of United States & international trademark and copyright law. The legal version of this story can be accessed at https://www.thecerbatgem.com/2017/11/12/genpact-limited-g-stock-rating-reaffirmed-by-robert-w-baird.html.

In related news, insider Mohit Thukral sold 25,000 shares of the business’s stock in a transaction dated Friday, August 25th. The stock was sold at an average price of $28.37, for a total transaction of $709,250.00. Following the completion of the transaction, the insider now directly owns 85,305 shares in the company, valued at $2,420,102.85. The transaction was disclosed in a document filed with the SEC, which is available through this link. Also, Director Amit Chandra sold 275,508 shares of the business’s stock in a transaction dated Friday, August 18th. The stock was sold at an average price of $28.72, for a total value of $7,912,589.76. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 10,396,187 shares of company stock worth $298,624,643. 1.41% of the stock is owned by insiders.

Hedge funds and other institutional investors have recently added to or reduced their stakes in the company. Alps Advisors Inc. raised its position in Genpact Limited by 0.3% during the 2nd quarter. Alps Advisors Inc. now owns 20,129 shares of the business services provider’s stock valued at $560,000 after purchasing an additional 52 shares during the last quarter. Bronfman E.L. Rothschild L.P. grew its stake in shares of Genpact Limited by 1.9% in the 2nd quarter. Bronfman E.L. Rothschild L.P. now owns 5,053 shares of the business services provider’s stock worth $141,000 after buying an additional 94 shares during the last quarter. Sawtooth Solutions LLC grew its stake in shares of Genpact Limited by 1.9% in the 2nd quarter. Sawtooth Solutions LLC now owns 9,034 shares of the business services provider’s stock worth $251,000 after buying an additional 165 shares during the last quarter. YorkBridge Wealth Partners LLC grew its stake in shares of Genpact Limited by 5.2% in the 2nd quarter. YorkBridge Wealth Partners LLC now owns 3,793 shares of the business services provider’s stock worth $106,000 after buying an additional 189 shares during the last quarter. Finally, The Manufacturers Life Insurance Company boosted its stake in Genpact Limited by 7.5% during the 2nd quarter. The Manufacturers Life Insurance Company now owns 6,508 shares of the business services provider’s stock valued at $181,000 after purchasing an additional 455 shares during the last quarter. 92.55% of the stock is owned by institutional investors.

About Genpact Limited

Genpact Limited is engaged in providing digitally powered business process management and services. The Company is also engaged in designing, transforming and running a combination of processes, as well as providing solutions that combine elements of its service offerings. The Company’s segments include Business process outsourcing and Information technology services.

Analyst Recommendations for Genpact Limited (NYSE:G)

Receive News & Stock Ratings for Genpact Limited Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Genpact Limited and related stocks with our FREE daily email newsletter.